Efficacy in the Reduction of Hypersensitivity During Home Whitening With 16% Carbamide Peroxide Applied on Alternate Days
Launched by UNIVERSIDAD REY JUAN CARLOS · Sep 12, 2023
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a teeth whitening treatment using a product called 16% carbamide peroxide, which is known to brighten teeth but can sometimes cause sensitivity. The trial aims to find out if using this whitening treatment every day for two hours is different from using it every other day in terms of how much dental sensitivity patients experience. Participants will be monitored over three weeks to see how their teeth react to the whitening process.
To participate in this study, individuals must be at least 18 years old and have healthy teeth that meet specific criteria, meaning no cavities or restorations and good oral hygiene. They also need to have teeth that are a certain shade of darkness to qualify. If you decide to join, you can expect to use the whitening trays for a set amount of time while being observed for any changes in sensitivity. It's important to note that certain individuals, such as those with specific dental issues or medical conditions, may not be eligible to participate to ensure everyone's safety during the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 18 years.
- • Patients with vital teeth without restorations, single crowns, implants and/or bridges at the level of the anterior teeth.
- • Absence of cavities in the teeth to be whitened.
- • Patients with satisfactory oral hygiene and periodontally healthy, who are not undergoing periodontal maintenance and who do not use chlorhexidine mouthwashes. Patients with recessions without presenting sensitivity will be included.
- • Absence of sensitivity, measured with the application of air with the dental team's syringe.
- • Patients whose canines have at least an A2-A3 shade (VITA Classic® Guide).
- Exclusion Criteria:
- • Patients who have previously undergone whitening (less than 5 years).
- • Patients undergoing orthodontic treatment.
- • Patients with white spots or alterations in the development of enamel or with stains.
- • Patients with a history of trauma to anterior teeth.
- • Patients who require internal whitening.
- • Smokers.
- • Pregnant or lactating.
- • Patients with allergies to any whitening component.
- • Patients presenting alterations of the oral mucosa (desquamative gingivitis, oral lichen planus, leukoplakia, etc.).
- • Patients with medical conditions considered by the researchers that may compromise the study or the individual safety of the patient.
- • Patients with poor oral hygiene.
- • Patients with previous hypersensitivity.
About Universidad Rey Juan Carlos
Universidad Rey Juan Carlos (URJC) is a prominent academic institution located in Madrid, Spain, dedicated to advancing knowledge and research in various fields, including health sciences. With a commitment to innovation and excellence, URJC actively engages in clinical trials aimed at improving patient care and outcomes. The university's multidisciplinary approach fosters collaboration among researchers, clinicians, and industry partners, ensuring that its clinical research is grounded in scientific rigor and ethical standards. Through its robust infrastructure and expertise, Universidad Rey Juan Carlos is poised to contribute significantly to the advancement of medical research and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcorcón, Madrid, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported